Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ATF5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
RPLP0 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SNAPIN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRG2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
VIM - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RAD52 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DUSP7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PPARA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ODC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMCO3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RNPEP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TSR3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UBE2S - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UNG - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FRY - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RRAS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ACLY - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRR11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATP2B2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IMPDH2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on